Search Share Prices
GSK Share Price - China approves GSK’s Nucala for adults with chronic lung disease
Investing.com -- China has approved GSK Plc ’s (LON:GSK) Nucala as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease marked by raised blood eosinophils, the company ...
Chiny zatwierdzają lek Nucala firmy GSK dla dorosłych z przewlekłą chorobą płuc
Brytyjska firma biofarmaceutyczna poinformowała, że Narodowa Administracja Produktów Medycznych Chin zatwierdziła lek, znany również jako mepolizumab, dla dorosłych, których POChP pozostaje słabo ...
GSK agrees to lower drug prices for Americans in deal with US government
Investing.com -- GSK plc (LON:GSK) has entered into an agreement with the U.S. government to reduce prescription medicine costs for American patients, particularly for its respiratory portfolio that ...
GSK lifts full-year guidance as Q3 profit more than doubles; shares jump 3%
Investing.com -- GSK Plc (LON:GSK) raised its full-year 2025 guidance after a strong third quarter, sending shares up over 3% on Wednesday as profit and earnings surged on strength in Specialty ...
GSK (LON:GSK) Will Pay A Dividend Of £0.16
The board of GSK plc (LON:GSK) has announced that it will pay a dividend on the 10th of July, with investors receiving £0.16 per share. This will take the dividend yield to an attractive 4.2%, ...
